Collaborative Research
We have entered into collaboration with few leading discovery R&D organization in India and the US for developing based and in-vitro assay system development for therapeutic mammalian and diagnostic platforms. These customized assay platforms is intended to give our collaborators a winning edge in fast tracking lead molecule identification and optimization processes. Our efforts in assay system development include customization of novel & existing mammalian cell lines for HTS applications against a variety of disease indications and multiplexing single cell line for each experiment (mainly for small molecule screening)
Assay System Development
We Develop innovative approaches for our partners for studies in
- Cytotoxicity & Cell Proliferation
- Invasion & Cell motility
- Cell Signaling & Apoptosis
- Pathway analysis
- Protein Phosphorylation profiling
- Cell cycle interference assays
- Gene Delivery using viral etc…
Specialized/customized GPCR Protocols
- Non-radioactive GPCR functional profiling
- Direct measurement of GPCR activation
- cAMP based cellular functional assays
- Intracellular calcium quantitation for GPCR activation
Angiogenesis assays for Drug Discovery
- angiogenic assays
- ECM remodeling drug identification
- 3-D Gel based assays
- Chorio Allantoic Membrane Assays for angiogenesis
We have experience with both established and primary cell lines
Custom Chip Design
ILS bioservices with its partnership with the industry´s leading names in DNA microarray and antibody platform technologies has initiated an ambitious“flexible’’ chip design project for multiplexing the array application for disease and molecular diagnostics. We anticipate tremendous difference in array sensitivity, comfort in use and speed of data generation once the FLEXI chips are made available to research community. We invite researchers to discuss with us about this concept in order to fast track the technology. We anticipate similar FLEXI chip application in microbial pathogenesis and food and drug safety apart from routine discovery research applications. For more details contact.
